Tata India Pharma & Healthcare Fund-Direct Plan-Growth

Factsheet

As of 31 Aug 2026

Inception

28 Dec 2015

Fund managers

Mr. Rajat Srivastava (since 16 Sep 2024)

Benchmark

BSE HC TRI

AUM

1565.28 crore

Regular expense

1.8%

Direct expense

0.62%

Portfolio turnover

0.51

Minimum investment

₹ 5,000

SIP minimum

₹ 100

Exit load

0.25% of NAV if redeemed/switched out before 30 days from the date of allotment. Base

Standard deviation

16.35%

Beta

0.96

Sharpe

0.87